Clinical trial · NCT05783908 · RECRUITING · NA
Impact of Non-magnetic Screen Respiratory Self-guidance During MRI-guided Radiotherapy Sessions for Mobile Lesions
Sponsor: Centre Georges Francois Leclerc
Summary
The patients eligible for the study are those treated by radiotherapy on Linac MRI for a mobile cancerous lesion (pancreas, liver, kidneys, adrenals, lung, adenopathy above or below the diaphragm ...). After signing the consent form, each patient will be randomized to one of two treatment arms: * Standard arm : Radiotherapy treatment with Linac MRI without non-magnetic shielding * Experimental arm : radiotherapy treatment with Linac MRI with non-magnetic screen The aim is to evaluate the effect of using a non-magnetic screen visible to the patient in the bunker during radiotherapy sessions delivered by Linac MRI on decreasing the ratio between the actual treatment time and the treatment time predicted by the machine.
Interventions
- With non-magnetic screen · COMBINATION_PRODUCT
Radiotherapy treatment with Linac MRI is performed with a non-magnetic screen that will guide the patient to block the breathing
Published eligibility criteria
Verbatim from the registry. Only the site can decide how these apply to a specific patient.
Inclusion Criteria: * Patient is at least 18 years old * Patient starting radiotherapy on Linac MRI for a mobile cancerous lesion most often in the pancreas, liver, kidneys, adrenals, lung, supra or subdiaphragmatic adenopathy * Patient affiliated to the social security system Exclusion Criteria: * Patient with lesions not detected by the device's tracking system * Patient with visual disturbances * Contraindications to treatment with Linac MRI (epileptic patients, pregnant or breastfeeding women, metallic prosthesis or pacemaker not compatible with MRI) * Patients with cognitive disorders * Persons deprived of liberty or under guardianship (including curatorship) * Pregnant or nursing woman * Refusal to participate in the study
Sites (1)
- Centre Georges-François Leclerc, Dijon, Côte d'Or, France · RECRUITING
Not medical advice. Trial0 is a navigation service, not a medical provider. Nothing here is medical advice or a recommendation to pursue any treatment; eligibility matching is informational, based on published registry criteria, and only the trial site or treating clinician can determine actual eligibility. Decisions belong with the patient and their own doctors. Registry data refreshed at most hourly; last update posted 2025-02-17.